Log In
Print
BCIQ
Print
Print this Print this
 

Ritalin, methylphenidate

Also known as: Ritalin LA

  Manage Alerts
Collapse Summary General Information
Company Celgene Corp.
DescriptionOnce-daily extended-release methylphenidate
Molecular Target Dopamine transporter
Mechanism of ActionDopamine and norepinephrine reuptake inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat attention deficit hyperactivity disorder (ADHD)
Regulatory Designation

Partner

Novartis AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today